Gene transfer of naked VEGF plasmid induces the formation of microvessels but not mature collaterals in ischaemic limb muscles

European Surgery - Acta Chirurgica Austriaca

Volumn 34, Issue 2, 2002, Pages 105-110

  Dulak, J ^a,b   Partyka, L ^a   Jozkowicz, Alicja ^a,c   Heba, G ^a   Prager, M ^c,f   Neumayer, Ch ^c,f   Sobhian, B ^d   Thurnher, M ^d   Nanobashvili, J ^c,f   Fugl A ^c,f   Ratajska, Anna ^e   Polterauer, P ^c,f   Pachinger, O ^b   Weidinger, F ^b   Dembinska Kiec, Aldona ^a   Redl, H ^d   Huk, I ^c,f  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d Ludwig Boltzmann Res Inst Exp C   (Austria)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f Ludwig Boltzmann Institut Health Promotion Research   (Austria)

Author keywords

Angiogenesis; Angiography; Gene therapy; Ischaemia; Vascular endothelial growth factor

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; NAKED DNA; PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD FLOW; CONFERENCE PAPER; CONTROLLED STUDY; GENE TRANSFER; LIMB; MICROVASCULATURE; MUSCLE ISCHEMIA; NONHUMAN; PLASMID; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RABBIT; RNA ANALYSIS;

EID: 0037002770     PISSN: 16821769     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1563-2563.2002.02034.x     Document Type: Conference Paper

References (35)

1. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM: Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnatal neovascularization. Circ Res 1998;83:233-240.
2. 165 gene transfer. Circulation 1996;94:3291-3302.
3. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF: Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 1994;89:2183-2189.
4. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97:1114-1123.
5. Bryans M., Kass S, Seivwright C, Adams RL: Vector methylation inhibits transcription from the SV40 early promoter. FEBS Lett 1992;309:97-102.
6. Grochot D, Florek I, Wojtowicz A, Szuba A, Cooke JP: Nitric oxide induces vascular endothelial growth factor-A synthesis by vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:659-666.
7. Dulak J, Józkowicz A, Guevara I, Dembińska-Kieć A: Gene transfer of vascular endothelial growth factor and endothelial nitric oxide synthase - implications for gene therapy in cardiovascular disease. Pol J Pharmacol 1999;51:233-241.
8. Dulak J, Józkowicz A, Ratajska A, Szuba A, Cooke JP, Dembińska-Kieć A: Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells. Vasc Med 2000;5:33-40.
9. Esakof DD, Maysky M, Losordo DW, Vale PR, Lathi K, Pastore JO, Symes JF, Isner JM: Intraoperative multiplane transesophageal echocardiography for guiding direct myocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris. Hum Gene Ther 1999;10:2307-2314.
10. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, Symes JF: Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg 1998;28:964-973.
11. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF: Clinical evidence of angiogenesis after arterial gene transfer of pHVEGF165 in patient with ischaemic limb. Lancet 1996;348:370-374.
12. Kaptchuk TJ: Myocardial gene transfer for patients with myocardial ischemia. Circulation 1999;100:108.
13. Laitinen M., Makinen K, Manninen H, Matsi P, Kossila M, Agrawal RS, Pakkanen T, Luoma JS, Viita H, Hartikainen J, Alhava E, Laakso M, Yla-Herttuala S: Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther 1998;9:1481-1486.
14. Lazarous DF, Shou M, Stiber JA, Hodge E, Thimmurti V, Goncalves L, Unger EF: Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Cardiovasc Res 1999;44:294-302.
15. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM: VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000;102:898-901.
16. 165 as sole therapy for myocardial ischemia. Circulation 1998;98:2800-2804.
17. Mack CA, Patel SR, Schwarz EA, Zanzonico P, Hahn RT, Ilercil A, Devereux RB, Goldsmith SJ, Christian TF, Sanborn TA, Kovesdi I, Hackett N, Isom OW, Crystal RG, Rosengart TK: Biological bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998;115:168-175.
18. Patel SR, Lee LY, Mack CA, Polce DR, El-Sawy T, Hackett NR, Ilercil A, Jones EC, Hahn RT, Isom OW, Rosengart TK, Crystal RG: Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gene Ther 1999;10:1331-1348.
19. 121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999;100:468-474.
20. Schaper W, Buschmann I: VEGF and therapeutic opportunities in cardiovascular diseases. Current Opinion Biotechnol 1999;10:541-543.
21. Shy KG, Manor O, Magner M, Yancopoulos GD, Isner JM: Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 1998;98:2081-2087.
22. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM: VEGF gene delivery to muscle: potential role for vasculogenesis in adults. Mol Cell 1998;2:549-558.
23. Symes JF, Losordo DW, Vale PR, Lathi KG, Esakof DD, Mayskiy M, Isner JM: Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 1999;68:830-836.
24. Takeshita S, Isshiki T, Mori H, Tanaka E, Tanaka A, Umetani K, Eto K, Miyazawa Y, Ochiai M, Sato T: Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats. Cardiovasc Res 1997;35:547-552.
25. Takeshita S, Isshiki T, Ochiai M, Ochiai M, Eto K, Mori H, Tanaka E, Umetani K, Sato T: Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia. Circulation 1998;98:1261-1263.
26. Takeshita S, Tsurumi Y, Couffinahl T, Asahara T, Bauters C, Symes J, Ferrara N, Isner JM: Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 1996;75:487-501.
27. Takeshita S, Weir L, Chen D, Zheng LP, Riessen R, Bauters C, Symes JF, Ferrara N, Isner JM: Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in rabbit model of hindlimb ischemia. Biochem Biophys Res Commun 1996;227:628-635.
28. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM: Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93:662-70.
29. Tio RA, Tkebuchava T, Scheuermann TH, Lebherz C, Magner M, Kearny M, Esakof DD, Isner JM, Symes JF: Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium. Hum Gene Ther 1999;10:2953-2960.
30. Tsurumi Y, Kearney M, Chen D, Silver M, Takeshita S, Yang J, Symes JF, Isner JM: Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997;96 (Suppl 9):382-388.
31. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow S, Passeri J, Symes JF, Isner JM: Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 1996;94:3281-3290.
32. Tzeng E, Yoneyama T, Hatakeyama K, Shears LL, Billiar TR: Vascular inducible nitric oxide synthase gene therapy: requirement for guanosine triphosphate cyclohydrolase I. Surgery 1995;120:315-321.
33. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995;92:1137-1141.
34. Zarrin AA, Malkin L, Fong I, Luk KD, Ghose A, Berinstein NL: Comparison of CMV, RS, SV40 viral and Vλ1 cellular promoters in B and T lymphoid and non-lymphoid cell lines. Biochim Biophys Acta 1999;1446:135-139.
35. Ziada AM, Hudlicka O, Tyler KR, Wright AJ: The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 1984;18:724-732.